These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1940476)

  • 21. Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection.
    Horsburgh CR; Ou CY; Jason J; Holmberg SD; Lifson AR; Moore JL; Ward JW; Seage GR; Mayer KH; Evatt BL
    J Infect Dis; 1990 Aug; 162(2):542-5. PubMed ID: 2373878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.
    Hu DJ; Subbarao S; Vanichseni S; Mock PA; van Griensven F; Nelson R; Nguyen L; Kitayaporn D; Young NL; Des Jarlais D; Byers R; Choopanya K; Mastro TD
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):240-7. PubMed ID: 12045687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection of baboons with simian/human immunodeficiency viruses.
    Allan JS; Ray P; Broussard S; Whitehead E; Hubbard G; Butler T; Brasky K; Luciw P; Cheng-Mayer C; Levy JA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):429-41. PubMed ID: 7627620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug users.
    Steger KA; Craven DE; Shea BF; Fitzgerald BR; Schwerzler M; Seage GR; Hoff R
    J Infect Dis; 1990 Oct; 162(4):964-7. PubMed ID: 2205655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan.
    Ichimura H; Kurimura O; Tamura I; Tsukue I; Tsuchie H; Kurimura T
    Int J STD AIDS; 1995; 6(6):441-3. PubMed ID: 8845404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the nef protein and to nef peptides in HIV-1-infected seronegative individuals.
    Ameisen JC; Guy B; Chamaret S; Loche M; Mouton Y; Neyrinck JL; Khalife J; Leprevost C; Beaucaire G; Boutillon C
    AIDS Res Hum Retroviruses; 1989 Jun; 5(3):279-91. PubMed ID: 2786420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 infection among injection and ex-injection drug users from Rio de Janeiro, Brazil: prevalence, estimated incidence and genetic diversity.
    Teixeira SL; Bastos FI; Telles PR; Hacker MA; Brigido LF; de F Oliveira CA; Bongertz V; Morgado MG
    J Clin Virol; 2004 Nov; 31(3):221-6. PubMed ID: 15465416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV type 1 incidence estimates by detection of recent infection from a cross-sectional sampling of injection drug users in Bangkok: use of the IgG capture BED enzyme immunoassay.
    Hu DJ; Vanichseni S; Mock PA; Young NL; Dobbs T; Byers RH; Choopanya K; van Griensven F; Kitayaporn D; McDougal JS; Tappero JW; Mastro TD; Parekh BS
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):727-30. PubMed ID: 14585202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of human immunodeficiency virus DNA using the polymerase chain reaction in a well-characterized group of homosexual and bisexual men.
    Lifson AR; Stanley M; Pane J; O'Malley PM; Wilber JC; Stanley A; Jeffery B; Rutherford GW; Sohmer PR
    J Infect Dis; 1990 Mar; 161(3):436-9. PubMed ID: 2313124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic tests: Human immunodeficiency virus type 1, type 2 (HIV-1, HIV 2)].
    Fujii T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():434-7. PubMed ID: 16111295
    [No Abstract]   [Full Text] [Related]  

  • 32. Human immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.
    Tsui R; Herring BL; Barbour JD; Grant RM; Bacchetti P; Kral A; Edlin BR; Delwart EL
    J Virol; 2004 Jan; 78(1):94-103. PubMed ID: 14671091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of human immunodeficiency virus type 1 by PCR before seroconversion in high-risk individuals who remain seronegative for prolonged periods.
    Gorriño MT; Campelo C; Suarez MD; Santamaría A; Malave C; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):271-6. PubMed ID: 8050445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The changing pattern of human immunodeficiency virus type 1 infection in intravenous drug users. Results of a six-year seroprevalence study in Palermo, Italy.
    Romano N; Vitale F; Alesi DR; Bonura F; La Licata R; Intonazzo V; Dardanoni G; Mammina C
    Am J Epidemiol; 1992 Jun; 135(11):1189-96. PubMed ID: 1626537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients.
    Chadwick EG; Yogev R; Kwok S; Sninsky JJ; Kellogg DE; Wolinsky SM
    J Infect Dis; 1989 Dec; 160(6):954-9. PubMed ID: 2685130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of drug-injection behavior on genetic evolution of HIV-1.
    Carneiro M; Yu XF; Lyles C; Templeton A; Weisstein AE; Safaeian M; Farzadegan H; Vlahov D; Markham RB
    J Infect Dis; 1999 Oct; 180(4):1025-32. PubMed ID: 10479127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection.
    Margolick JB; Muñoz A; Vlahov D; Solomon L; Astemborski J; Cohn S; Nelson KE
    JAMA; 1992 Mar; 267(12):1631-6. PubMed ID: 1347321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1.
    Anthony JC; Vlahov D; Nelson KE; Cohn S; Astemborski J; Solomon L
    Am J Epidemiol; 1991 Nov; 134(10):1175-89. PubMed ID: 1746528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection by polymerase chain reaction of human immunodeficiency virus type 1 proviral DNA sequences in needles of injecting drug users.
    Heimer R; Myers SS; Cadman EC; Kaplan EH
    J Infect Dis; 1992 Apr; 165(4):781-2. PubMed ID: 1552214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.